<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><condition>Polyp of colon</condition><condition>Malignant neoplasm of colon, unspecified</condition><disease>Polyp Of Colon</disease><disease>Malignant Neoplasm Of Colon, Unspecified</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/76824</full_dataset_link><location>India</location><study_start_month>5</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>To study gene mutations in colorectal cancer enzymatically.</name><description>Primary outcome(s): The primary outcome of the study will be assessment of immunopositivity of BRAF in precancerous and cancerous lesions of colorectum.Timepoint: 2 years</description><dates><creation>2023-05-15</creation></dates><accession>76824</accession><cross_references><Clinical Trials Registry - India>CTRI-2023-05-053332</Clinical Trials Registry - India></cross_references></HashMap>